Even though more investigations are required to determine the contribution of these differences in mRNA levels of eNOS, VEGF, A20 and HIF-1α to the pathophysiology of OSA-induced vascular dysfunction, these genes represent potential markers distinguishing mildly from severely hypoxemic OSA patients. The gene discussed is VEGFA; the disease is obstructive sleep apnea syndrome.